Skip to main content
Premium Trial:

Request an Annual Quote

Genisphere Licenses Signal Amplification Technology to Chembio

NEW YORK (GenomeWeb News) – Genisphere said today it has licensed its 3DNA Signal Amplification technology to Chembio Diagnostics.

Chembio will use the technology for its Dual Path Platform rapid diagnostic pipeline tests in order to achieve detection limits "unique to rapid immunoassays, thereby broadening potential applications of its technology by combining it with the Genisphere technology," Hatfield, Penn.-based Genisphere said.

Its 3DNA Dendrimer technology can provide up to 100-fold improvement in sensitivity without increasing the assay's complexity, it said, adding that the improvement enables point-of-care analyses that has not been possible with conventional technologies.

Today's deal follows a feasibility study in which Genisphere demonstrated 3DNA Dendrimer can be adapted to Chembio's Dual Path Platform.

Financial and other terms were not disclosed.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.